EMA publishes revised guidelines on antibacterial drug development
The European Medicines Agency (EMA) has published revised guidelines on the development and...
Trending menu:
Most Read
Latest Content
CLIOSS adopts Veeva Vault solutions for trial management
Clinical Organization for Strategies & Solutions (CLIOSS), an Italian clinical trial services provider, has partnered with Spain-based Veeva Systems to optimise trial management for sponsors.
TrialScope partners with Vivli on trial data transparency
TrialScope, a clinical trial transparency and compliance solutions company, has formed a strategic alliance with not-for-profit trial data sharing platform provider Vivli to cater to increasing transparency needs in the industry.
HSBlox launches blockchain solution for trial sample management
HSBlox, a healthcare solutions provider, has introduced blockchain-based Digital Sample Manager (DSM) for end-to-end sample tracking in clinical trials.
Umbrella trial for lung cancer precision medicine expands access
A precision medicine clinical trial for lung cancer, featuring umbrella design, has been opened to individuals with all types of non-small cell lung cancers.
EMA publishes revised guidelines on antibacterial drug development
The European Medicines Agency (EMA) has published revised guidelines on the development and evaluation of human medicines intended to treat bacterial infections.
Observations from GCP Sponsor Inspections
Kevin Anderson, Director, Global Clinical Operations, Alexion Pharmaceuticals, offers a perspective on what he has observed in various GCP inspections
Is the GAIN Act Stimulating Antibiotic R&D?
Christopher J. Pace, PhD, Director of Infectious Diseases, GlobalData, assesses the impact of the GAIN Act
Latest News
Go Top
